DAP12 Activators
DAP12 activators represent a diverse class of chemicals that influence the activity of DNAX-activating protein of 12 kDa (DAP12), a transmembrane adaptor protein crucial for immune cell signaling. While direct activators of DAP12 are limited, several compounds indirectly modulate its activity through various signaling pathways and cellular processes. One group of DAP12 activators includes SYK kinase inhibitors such as R406 and entospletinib. These compounds indirectly activate DAP12 by modulating SYK kinase signaling, a key player in immune cell activation. Inhibition of SYK by these compounds influences downstream events, potentially impacting DAP12 expression and contributing to the regulation of immune responses and inflammatory processes. Another class of DAP12 activators involves vacuolar-type H+-ATPase inhibitors like bafilomycin A1. These compounds indirectly activate DAP12 by influencing lysosomal function. Inhibition of vacuolar-type H+-ATPase impacts lysosomal acidification, potentially affecting DAP12 trafficking and expression. This indirect activation highlights the connection between lysosomal processes and DAP12 regulation, contributing to immune responses and cellular functions.
Furthermore, mTOR inhibitors like rapamycin indirectly activate DAP12 by modulating mTOR signaling. Inhibition of mTOR influences downstream events, potentially impacting DAP12 expression. This indirect activation emphasizes the intricate crosstalk between mTOR signaling and DAP12 regulation, affecting immune cell function and inflammatory responses. MEK1/2 inhibitors like U0126 indirectly activate DAP12 by affecting the MAPK/ERK pathway. Inhibition of MEK1/2 influences downstream events, potentially impacting DAP12 expression. This indirect activation underscores the connection between U0126, MAPK/ERK signaling, and DAP12 regulation, contributing to immune responses and cellular processes. Src family kinase inhibitors like PP2 indirectly activate DAP12 by modulating Src kinase signaling. Inhibition of Src family kinases influences downstream events, potentially impacting DAP12 expression. This indirect activation emphasizes the complex interplay between PP2, Src kinase signaling, and DAP12 regulation, affecting immune cell function and inflammatory responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, a selective estrogen receptor modulator, indirectly activates DAP12 by influencing estrogen receptor signaling. Modulation of estrogen receptors by tamoxifen impacts downstream events, potentially affecting DAP12 expression. This indirect activation highlights the interplay between estrogen signaling and DAP12 regulation, contributing to immune responses and cellular processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1, a vacuolar-type H+-ATPase inhibitor, indirectly activates DAP12 by influencing lysosomal function. Inhibition of vacuolar-type H+-ATPase by bafilomycin A1 impacts lysosomal acidification, potentially affecting DAP12 trafficking and expression. This indirect activation underscores the connection between lysosomal processes and DAP12 regulation, contributing to immune responses and cellular functions. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural polyphenol, indirectly activates DAP12 by modulating NF-κB signaling. Inhibition of NF-κB by curcumin influences downstream events, potentially impacting DAP12 expression. This indirect activation highlights the interplay between curcumin, NF-κB signaling, and DAP12 regulation, contributing to immune responses and cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, indirectly activates DAP12 by modulating mTOR signaling. Inhibition of mTOR by rapamycin influences downstream events, potentially impacting DAP12 expression. This indirect activation emphasizes the intricate crosstalk between mTOR signaling and DAP12 regulation, affecting immune cell function and inflammatory responses. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, indirectly activates DAP12 by modulating PI3K/Akt signaling. Inhibition of PI3K by wortmannin influences downstream events, potentially impacting DAP12 expression. This indirect activation highlights the intricate crosstalk between Wortmannin, PI3K/Akt signaling, and DAP12 regulation, affecting immune cell function and inflammatory responses. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src family kinase inhibitor, indirectly activates DAP12 by modulating Src kinase signaling. Inhibition of Src family kinases by PP2 influences downstream events, potentially impacting DAP12 expression. This indirect activation emphasizes the complex interplay between PP2, Src kinase signaling, and DAP12 regulation, affecting immune cell function and inflammatory responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, indirectly activates DAP12 by affecting the p38 MAPK pathway. Inhibition of p38 MAPK by SB203580 influences downstream events, potentially impacting DAP12 expression. This indirect activation underscores the connection between SB203580, p38 MAPK signaling, and DAP12 regulation, contributing to immune responses and cellular processes. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082, an NF-κB inhibitor, indirectly activates DAP12 by modulating NF-κB signaling. Inhibition of NF-κB by Bay 11-7082 influences downstream events, potentially impacting DAP12 expression. This indirect activation highlights the intricate crosstalk between Bay 11-7082, NF-κB signaling, and DAP12 regulation, contributing to immune responses and cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, indirectly activates DAP12 by affecting the JNK pathway. Inhibition of JNK by SP600125 influences downstream events, potentially impacting DAP12 expression. This indirect activation underscores the connection between SP600125, JNK signaling, and DAP12 regulation, contributing to immune responses and cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly activates DAP12 by modulating PI3K/Akt signaling. Inhibition of PI3K by LY294002 influences downstream events, potentially impacting DAP12 expression. This indirect activation emphasizes the intricate crosstalk between LY294002, PI3K/Akt signaling, and DAP12 regulation, affecting immune cell function and inflammatory responses. | ||||||